-+ 0.00%
-+ 0.00%
-+ 0.00%

Freedom Capital Markets Maintains Hold on AtriCure, Maintains $57 Price Target

Benzinga·11/18/2026 12:27:19
Listen to the news
Freedom Capital Markets analyst Keith Hinton maintains AtriCure (NASDAQ:ATRC) with a Hold and maintains $57 price target.